Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism
Public ClinicalTrials.gov record NCT00872898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label (Part One) and a Randomized, Double-blind, Placebo-Controlled (Part Two) Study of the Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Pediatric Patients With Autism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the safety and efficacy of memantine extended release, as well as its extent of absorption in pediatric patients with autism.
Study identification
- NCT ID
- NCT00872898
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 124 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2009 (Type not available)
- Primary completion
- Aug 2012 (Actual)
- Completion
- Not listed
- Last update posted
- Jan 14, 2014
Started 2009
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site | Phoenix | Arizona | 85006 | — |
| Forest Investigative Site | Sacramento | California | 95817 | — |
| Forest Investigative Site | San Francisco | California | 94143 | — |
| Forest Investigative Site | Santa Ana | California | 92705 | — |
| Forest Investigative Site | Stanford | California | 94305 | — |
| Forest Investigative Site | Jacksonville Beach | Florida | 32250 | — |
| Forest Investigative Site | St. Petersburg | Florida | 33701 | — |
| Forest Investigative Site | Hoffman Estates | Illinois | 60169 | — |
| Forest Investigative site | Naperville | Illinois | 60563 | — |
| Forest Investigative Site | Indianapolis | Indiana | 46202 | — |
| Forest Investigative Site | Cambridge | Massachusetts | 02138 | — |
| Forest Investigative Site | Toms River | New Jersey | 08755 | — |
| Forest Investigative Site | Voorhees Township | New Jersey | 08043 | — |
| Forest Investigative Site | Manhasset | New York | 11030 | — |
| Forest Investigative Site | Cleveland | Ohio | 44106 | — |
| Forest Investigative Site | Columbus | Ohio | 43210 | — |
| Forest Investigative Site | Oklahoma City | Oklahoma | 73116 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00872898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2014 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00872898 live on ClinicalTrials.gov.